NCT00664742View on ClinicalTrials.gov

The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

614

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Metabolic Syndrome
Interventions
DRUG

Fluvastatin XL®

Fluvastatin extended release 80 mg

Trial Locations (1)

Unknown

Götzepe Education and Research Hospital, Istanbul

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY